These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22372105)

  • 1. [Ensuring the safety of donated blood].
    Danic B
    Rev Infirm; 2012 Jan; (177):18-20. PubMed ID: 22372105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The six questions of pathogen reduction technology: an overview of current opinions.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2008 Aug; 39(1):51-7. PubMed ID: 18614401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion safety: is this the business of blood centers?
    Slapak C; Fredrich N; Wagner J
    Transfusion; 2011 Dec; 51(12 Pt 2):2767-71. PubMed ID: 22150688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stating technical requirements and deferral criteria for whole blood donation].
    Danic B
    Transfus Clin Biol; 2005 Jul; 12(3):287-9. PubMed ID: 15963750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug use in blood donors].
    Berg JA; Schjøtt J
    Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine?
    Juhl D; Mosel C; Nawroth F; Funke AM; Dadgar SM; Hagenström H; Kirchner H; Hennig H
    Transfus Med; 2010 Feb; 20(1):38-47. PubMed ID: 19708895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative risk of reducing the lifetime blood donation deferral for men who have had sex with men versus currently tolerated transfusion risks.
    Vamvakas EC
    Transfus Med Rev; 2011 Jan; 25(1):47-60. PubMed ID: 21134626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferral patterns of voluntary blood donors at the National Blood Transfusion Service, North East Zonal Centre, Maiduguri.
    Kagu MB; Ahmed SG; Bashir MA; Malah MB; Usoro A; Gimba I; Babakura Y; Elisha J
    Afr J Med Med Sci; 2010 Jun; 39(2):119-25. PubMed ID: 21117408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practices in regulation of blood and blood products.
    Epstein JS
    Biologicals; 2012 May; 40(3):200-4. PubMed ID: 22122986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa.
    Tagny CT; Diarra A; Yahaya R; Hakizimana M; Nguessan A; Mbensa G; Nébié Y; Dahourou H; Mbanya D; Shiboski C; Murphy E; Lefrère JJ
    Transfusion; 2009 Aug; 49(8):1592-9. PubMed ID: 19389036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood donation in Chile: Replacement and volunteer donors.
    Herrera C; Martínez C; Armanet L; Cárcamo A; Boye P; Lyng C
    Biologicals; 2010 Jan; 38(1):36-8. PubMed ID: 19926303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria.
    Seed CR; Kee G; Wong T; Law M; Ismay S
    Vox Sang; 2010 Apr; 98(3 Pt 1):e182-92. PubMed ID: 19744194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful exclusion of blood-borne viral disease in blood donors.
    Ramezani H; Bozorgi SH; Nooranipour M; Sadri M; Molaverdikhani S; Alavian SM
    Eur J Intern Med; 2011 Dec; 22(6):e71-4. PubMed ID: 22075316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety.
    Teo D
    Biologicals; 2012 May; 40(3):169. PubMed ID: 22507451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.